Mark Devlin
Corporate Officer/Principal bei AMPLIA THERAPEUTICS LIMITED
Profil
Mark Devlin is currently working as a Scientific Adviser at Amplia Therapeutics Ltd.
Previously, he held positions as the Chief Executive Officer at CTxONE, the Chief Operating Officer at Cancer Therapeutics CRC Pty Ltd., and an Associate Professor at Peter MacCallum Cancer Institute.
Dr. Devlin has an MBA from Melbourne Business School and a doctorate from the University of Melbourne.
Aktive Positionen von Mark Devlin
Unternehmen | Position | Beginn |
---|---|---|
AMPLIA THERAPEUTICS LIMITED | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mark Devlin
Unternehmen | Position | Ende |
---|---|---|
Cancer Therapeutics CRC Pty Ltd.
Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Chief Operating Officer | 01.09.2019 |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Peter MacCallum Cancer Institute is a world-renowned cancer research, education, and treatment center. The non-profit company is based in Melbourne, Australia. The institute is dedicated to providing care for individuals affected by cancer. | Corporate Officer/Principal | 01.09.2019 |
CTxONE | Chief Executive Officer | - |
Ausbildung von Mark Devlin
Melbourne Business School | Masters Business Admin |
University of Melbourne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AMPLIA THERAPEUTICS LIMITED | Health Technology |
Private Unternehmen | 3 |
---|---|
Cancer Therapeutics CRC Pty Ltd.
Cancer Therapeutics CRC Pty Ltd. BiotechnologyHealth Technology Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia. | Health Technology |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Peter MacCallum Cancer Institute is a world-renowned cancer research, education, and treatment center. The non-profit company is based in Melbourne, Australia. The institute is dedicated to providing care for individuals affected by cancer. | Government |
CTxONE |